When does Tezspire’s patent expire?
Tezspire (tezepelumab) is protected by patents tied to its biologic product and related manufacturing/usage claims. The exact expiration date depends on which specific patent(s) are being counted (primary patent term vs. patent term adjustments, and any data/exclusivity protections that may extend market exclusivity beyond patent expiry).
For the most current, patent-by-patent view of Tezspire’s protection timeline, including expiration dates by listed patents, check DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Tezspire” on the site). [1]
Does market exclusivity end on the same day as patent expiry?
Not necessarily. Even after a patent expires, other forms of exclusivity (or other still-in-force patents covering formulation, dosing, or manufacturing) can keep competitors off the market for longer than the first patent expiration date alone. This is why Tezspire’s practical “entry window” for generics/biosimilars often tracks the last blocking patent and any additional exclusivities, not just one date. [1]
How do I find the exact expiration date for “Tezspire” for a specific claim?
“Tezspire patent expiration date” can refer to different events:
- the earliest patent that bars competitors,
- the last patent that still blocks biosimilar approval/launch,
- or a patent that covers a specific method/use.
DrugPatentWatch.com organizes this by listing the patents and their projected expiration dates, which is usually the fastest way to identify which one matches your question. [1]
What to search next if you’re tracking biosimilar entry
If your goal is to estimate when a biosimilar could launch, look for:
- the latest-expiring Tezspire patents (not just the first),
- any related patent families,
- and which regulatory exclusivities apply.
DrugPatentWatch.com’s patent lists are typically the starting point for that timeline research. [1]
Sources
- https://www.drugpatentwatch.com/